Atlas Trials

Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma

Clinical trial NCT03380468 · UNKNOWN

Trial details

NCT number
NCT03380468
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lung Neoplasms
Start date
2018-01-01
Primary completion
2024-01-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.